Biocon Limited has completed the acquisition of the remaining 7.18 crore equity shares of Biocon Biologics Limited (BBL) from Mylan Inc. for USD 200 million. This follows an earlier tranche of equal size acquired in January 2026. With this, Biocon now holds nearly 98% of BBL’s equity capital.
Show moreStay Ahead – Explore Now! French Flair vs. Japanese Struggle: Renault Surges, Nissan Slips in Dec 2025 Sales
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
